Use of Omega-3 Fat Emulsion (Omegaven) in Infants With Parenteral Nutrition Associated Liver Disease
Status:
Completed
Trial end date:
2019-10-01
Target enrollment:
Participant gender:
Summary
Babies in the newborn intensive care unit who are dependent upon intravenous nutrition for a
long period of time frequently develop liver damage. The fat used is called intralipid and is
made from soybean oil. There is a suggestion in the literature that using fish oil based fats
called omega-3 fat emulsions can decrease or even reverse this liver damage. We will offer
babies with evidence of liver damage and no ability to eat,the Omegaven and see if the liver
damage reverses.